Mark Your Calendar for EU Pharmaceutical Law Forum 2024!
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels
JOIN LATHAM & WATKINS AT EU PHARMACEUTICAL LAW FORUM 2023
Merger Control and Expanded Jurisdictional Reach: Lessons from Illumina/Grail Case
Tuesday 23 May, 9:45am
- Experience in the Illumina / Grail case: examining the procedural aspects and merits of the case, and the on-going gun jumping investigation
- Are the theories of harm damaging innovation?
- Commercial implications precautionary advice from the Illumina/Grail case
- Review of wider merger control cases
PRESENTED BY:
Industry Impact the EU Pharmaceutical Legislation Revision
Wednesday 24 May, 9:30am
Assessing new legislation against its objectives for innovation and availability of medicines
Industry perspective on incentives for investment in R&D in the European Union
How do you define unmet medical needs? Definition(s), implications, and risks
Will the revisions stimulate the development in areas of high need, such as rare childhood diseases? And to combat anti-microbial resistance?
PRESENTED BY:
YOU'RE INVITED TO THE EU PHARMACEUTICAL LAW FORUM WITH AN EXCLUSIVE 10% DISCOUNT*
We are excited to announce that Latham & Watkins will be participating at the EU Pharmaceutical Law Forum on 23 - 25 May 2023 at the Steigenberger Wiltcher's Hotel, Brussels And, we are pleased to let you know that as a valued client of Latham & Watkins, we have an exclusive 10% discount* for you. Your VIP discount code is: P23EUPLLATHAMWATKINS
T&C's Apply